Cargando…
Bcl-2 expression predicts radiotherapy failure in laryngeal cancer
Early stage laryngeal cancer can be effectively cured by radiotherapy or conservative laryngeal surgery. In the UK, radiotherapy is the preferred first line treatment. However, up to 25% of patients with T2 tumours will demonstrate locally persistent or recurrent disease at the original site, requir...
Autores principales: | Nix, P, Cawkwell, L, Patmore, H, Greenman, J, Stafford, N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361818/ https://www.ncbi.nlm.nih.gov/pubmed/15928664 http://dx.doi.org/10.1038/sj.bjc.6602647 |
Ejemplares similares
-
Cortactin expression predicts poor survival in laryngeal carcinoma
por: Gibcus, J H, et al.
Publicado: (2008) -
Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation
por: Ashman, J N E, et al.
Publicado: (2003) -
An antiapoptotic Bcl-2 family protein index predicts the response of leukaemic cells to the pan-Bcl-2 inhibitor S1
por: Zhang, Z, et al.
Publicado: (2013) -
Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma
por: Yoshimine, S, et al.
Publicado: (2013) -
Bcl-2 and β(1)-integrin predict survival in a tissue microarray of small cell lung cancer
por: Lawson, M H, et al.
Publicado: (2010)